Amin Adibi
Doctor of Philosophy in Pharmaceutical Sciences (PhD)
Taking a Deep Breath: Insightful Discourses on Race and Spirometry Through Patient Engagement
Review details about the recently announced changes to study and work permits that apply to master’s and doctoral degree students. Read more
If you are passionate about health sciences research that makes a difference in people's lives, you're in good hands. We offer award-wining graduate programs led by world-class researchers. You'll have access to top-tier facilities and be working alongside the best and brightest in the field, conducting research that addresses real life problems. Our paradigm-changing approach is collaborative, innovative, and results-driven.
We're tackling diseases like asthma / chronic obstructive pulmonary disease, diabetes, cancer, heart disease, and arthritis. We're developing better ways to deliver drugs and prevent adverse drug reactions. And we're conducting clinical and economic research in pharmaceutical outcomes.
Our reputation as a top research centre attracts some of the brightest and most productive minds in the field. Our faculty includes Canada Research Chairs, Michael Smith Foundation for Health Research Scholars and Senior Scholars, and Distinguished University Scholars.
We are innovators in pharmacy education, research and practice, with the goal of supporting the optimization of drug therapy in the pursuit of improved patient outcomes.
adMare BioInnovations is located in our building. It is an independent, non-profit organization with a focus on bridging the gap between academic discoveries in the health sciences and the development of new medicines to treat human disease. The Faculty partners with adMare BioInnovations to provide unique research and mentoring opportunities for MSc and PhD students.
We are also home to several sophisticated research centres that specialize in the areas of human genome and exome sequencing, and health outcomes research.
Opened in 2012, the Pharmaceutical Sciences Building at UBC is a state-of-the-art learning and research facility. The building houses modern, modular labs designed specifically for the type of research intended for the space. Our classroom facilities are fitted with advanced technology to facilitate new modes of learning.
Measuring 246,000 square feet, it's an eye-catching addition to our campus, and has drawn attention and admiration from around the world—including 15 awards of excellence.
As a leading research faculty, we conduct ground-breaking research in the pharmaceutical sciences – all with the goal of addressing the pressing health needs of society and improving lives. Our research activities centre around four areas of focus.
This theme covers our activities in epidemiological analysis, health outcomes and health economics research seeking solutions for the predictive enhancement of intervention strategies for practical and preventive healthcare. The impact of this work is used to shape policy to optimize the allocation of health care resources as well as defining the efficacy of healthcare interventions and strategy.
This highly interdisciplinary theme embodies research directed at the interactions of therapeutic agents with human cells, and covers fundamental questions of the mechanisms of the drug action through to the behaviour of drugs in human systems. These studies are used to inform and optimize the development and delivery of drug intervention regimes for clinical practice and the pharmaceutical industry.
This theme applies our expertise in the chemical biology of the fabrication and handling of nanoscopic materials to drug discovery and delivery. Sensing and screening technologies are also an important focus.
Our research in this theme addresses the issue of scholarship in pharmacy and the pharmaceutical sciences with a view to augment our educational research capacity and enhance the methodologies of teaching practice, student learning and curriculum decision-making.
Name | Research Interests |
---|---|
Cairns, Brian | Neurosciences, biological and chemical aspects; Neurosciences, medical and physiological and health aspects; Pharmacology and pharmaceutical sciences (except clinical aspects); electrophysiology; headache; Neuropharmacology; Oro-Facial Pain; pain; pain mechanisms; peripheral analgesics; sex-related differences; temporomandibular disorders |
Chang, Thomas | Pharmacology and pharmaceutical sciences (except clinical aspects) |
Conklin, Annalijn | Public health nutrition policy; Other basic medicine and life sciences; Social Determinants of Dietary and Metabolic Disorders; social nutritional epidemiology; Gender Epidemiology; women's health; Health Equity; Chronic Diseases in Elderly; Obesity; CVD risk factors; healthy ageing; food and nutrition policy; Indigenous health; Community Health / Public Health; disease management evaluation; healthcare quality improvement; Professional Practices; ethics of research and public health |
Coughtrie, Michael | Drug metabolizing enzymes |
Cragg, Jacquelyn | Epidemiology (except nutritional and veterinary epidemiology); data science; open science; Causal inference; Drug Effectiveness; Drug Safety; Epidemiology; neuro-epidemiology; Neurological diseases; Spinal cord injury; Amyotrophic Lateral Sclerosis (ALS); multiple sclerosis; Parkinson’s disease |
De Vera, Mary | examining how eHealth technologies can support new and existing models of care to improve care delivery and patient outcomes; exploring patients' perspectives and experiences with medication taking and adherence; and evaluating the use and impacts of medications among pregnant women, particularly with inflammatory conditions. |
Finbloom, Joel | Drug discovery, design and delivery; Biologically active molecules; Nanochemistry; Antimicrobial resistance; Nanomedicine; nanomedicine; Chemical Biology; drug delivery; Pharmaceutical Sciences; Infectious disease; Bacterial Biofilms; Microbiome; Probiotics; Antibiotic resistance |
Frankel, Adam | Other basic medicine and life sciences; Enzymes (including kinetics and mechanisms, and biocatalyst); Protein Biochemistry; arginine methylation; Histones; Nucleosomes; post-translational modifications; Biological and Biochemical Mechanisms; Organic Molecules and Biomolecules; Bioactive Molecules; Proteins; Chemical Biology; drug discovery; Target Engagement; yeast; Amino acids |
Giaever, Guri | Model organisms, human therapeutics, high-throughput cell biology, drug synergy, technologies for understanding relationship between chromatic structure and transcriptional regulation |
Harrison, Mark | measurement and valuation of health, health technology and policy assessment, and preferences for healthcare interventions; evaluation/re-evaluation of the type of health care that is provided, the point in the treatment pathway, and the way in which it is delivered |
Jarvis-Selinger, Sandra | Education, human learning, development, and instruction, education innovation, konwledge translation, teaching excellence, curriculum design, technology |
Johnson, Kate | Health Outcomes |
Krentz, Nicole | Human development and organogenesis; Pharmacology and pharmaceutical sciences, n.e.c.; Human physiology, n.e.c.; Diabetes; Developmental biology; Genetics |
Kumar, Ujendra | Somatostatin hormone, molecular pharmacology, Somatostatin, , Hormones, somatostatin, locomotor and cognitive function, neurodegenerative diseases, drugs |
Lalji, Fawziah | Epidemiology (except nutritional and veterinary epidemiology); Pharmacoepidemiology; Infectious diseases; Immunization; Antibiotics and Resistance; Vaccine preventable diseases |
Li, Shyh-Dar | Drug discovery, design and delivery; Nano-technology; biopharmaceutics; drug delivery; nanomedicine; pharmaceutics; Gene delivery and therapy |
Loewen, Peter | Cardiology and circulatory sciences (including cardiovascular disease); Clinical pharmacy and pharmacy practice; Knowledge translation and implementation science in health; atrial fibrillation; Pharmacoepidemiology; Thrombosis and Embolism; adherence to medication; Cardiovascular diseases; Arrhythmia; Heart Failure; stroke; Health Care Technologies; Professional Practices; Hematology; decision making; clinical prediction rules; healthcare communication technologies; hospital pharmacy practice; knowledge translation of evidence to patient care; patient complexiometry; patient decision aids; patient education; pharmacy practice; prediction of stroke and bleeding in atrial fibrillation patients; quality of care, quality drug therapy; Shared decision-making; stroke prevention therapy; use of mobile technology for clinical decision-making |
Lynd, Larry | health economics, orphan drugs, pharmaceutical policy, respiratory medicine, epidemiology, pharmacoepidemiology, rare diseases |
Maharaj, Anil | Pharmacology and pharmaceutical sciences, n.e.c.; Pharmacometrics; Pharmacokinetics/Pharmacodynamics; Obstetric and Pediatric Pharmacology |
McCormack, James | Knowledge translation and evidence-based practice |
Nislow, Corey | genomics and develops biotechnology tools to address both fundamental and applied biological questions; Parallel genome-wide chemical genomic screens; High throughput cell-based screens; Next Generation Sequencing |
Page, Brent | Drug discovery, design and delivery; Cell Signaling and Cancer; Cancer; Cell signaling; Chemical Biology; Drug development; Drug Discovery, Design and Delivery; Medicinal Chemistry; Target Engagement |
Rodrigues, Brian | Pharmacology and pharmaceutical sciences (except clinical aspects); Diabetes; Cardiomyopathy; Heart Failure; Energy Metabolism; Cardiovascular metabolism; Endothelial cell - cardiomyocyte crosstalk; Vascular Endothelial Growth factors |
Ross, Colin | Genetic medicine; Genomics; Neurosciences, biological and chemical aspects; Neurosciences, medical and physiological and health aspects; Pharmacology and pharmaceutical sciences (except clinical aspects); Biomedical Technologies; Drug Metabolism; Gene Therapy; Gene-based therapeutics; Pharmacogenomics; Precision Medicine; Transgenic Model |
Sadatsafavi, Mohsen | Respiratory diseases; Epidemiology (except nutritional and veterinary epidemiology); Epidemiology; Biostatistics; Respiratory Research |
This is an incomplete sample of recent publications in chronological order by UBC faculty members with a primary appointment in the Faculty of Pharmaceutical Sciences.
Year | Citation | Program |
---|---|---|
2024 | Dr. Howren examined the relationship between mental disorders and arthritis and whether people with arthritis receive adequate care for depression or anxiety. Her research demonstrates arthritis has an underlying relationship with depression and anxiety, that mental disorders are substantially undertreated, and that mental health care needs are largely unmet. | Doctor of Philosophy in Pharmaceutical Sciences (PhD) |
2024 | Dr. Bergamo investigated the use of albumin aggregates as a formulation for the delivery of a fibrinolytic enhancer to the lungs. With this research the potential of using a diagnostic tool such as albumin microparticles for a therapeutic purpose was explored. | Doctor of Philosophy in Pharmaceutical Sciences (PhD) |
2024 | Dr. Wu's research revolutionizes protein drug delivery, addressing medicine adherence and effectiveness. He developed a needle-free platform using cell-penetrating peptides (CPPs), enhancing insulin delivery and blood glucose control. His Nano formulations promise breakthroughs in treating chronic conditions by delivery of monoclonal antibody. | Doctor of Philosophy in Pharmaceutical Sciences (PhD) |
2023 | Dr. Hohenwarter developed a painkiller derived from an endogenous opioid peptide. He demonstrated the effectiveness of this novel compound in reducing pain and depression, without inducing dangerous opioid-related side effects. This new painkiller may be a safe alternative to opioids for persistent pain treatment and help fight the opioid crisis. | Doctor of Philosophy in Pharmaceutical Sciences (PhD) |
2023 | Dr. Saatchi examined outpatient antibiotic use in British Columbia and Ontario, Canada. Appropriate antibiotic use is integral to mitigate the impacts of antibacterial resistance. This epidemiological research elucidates new targets for antimicrobial stewardship efforts and offers the first interpretations of inter-provincial prescribing quality. | Doctor of Philosophy in Pharmaceutical Sciences (PhD) |
2023 | Dr. Saxena developed a novel oral delivery system called sorbops that can improve the oral delivery of compounds and biomolecules which would normally get degraded in the gastrointestinal tract. She subsequently tested the efficiency of sorbops in different cell lines and mice using SPECT/CT imaging thereby, showing higher amounts of drug uptake in the target sites. | Doctor of Philosophy in Pharmaceutical Sciences (PhD) |
2023 | Dr. Bohrmann used click chemistry to generate tumor specific nanoprobes and to evaluate novel radiotracers for pretargeted imaging. His research showcases opportunities and challenges for the further development of aptamer-based imaging probes and may contribute to the further development of technetium-99m labeled radiotracers. | Doctor of Philosophy in Pharmaceutical Sciences (PhD) |
2023 | Dr. Yu developed and validated two novel reporter gene mouse models that can quickly measure the effectiveness of genome editing in animals. They are valuable tools to evaluate and optimize new ways to deliver gene editors into various tissues. The long-term goal of this research is to improve the safety and efficacy of genome-targeted therapeutics. | Doctor of Philosophy in Pharmaceutical Sciences (PhD) |
2023 | Dr. Shang examined the metabolic effects of a growth factor, VEGFB, in the heart under normal conditions and following diabetes. Her research brings attention to fat utilization as an additional means for development of diabetic heart disease. Her findings are expected to advance the clinical management of this complication seen with diabetes. | Doctor of Philosophy in Pharmaceutical Sciences (PhD) |
2023 | Dr. Khanna examined how nanoscale flow cytometry could improve the analysis and isolation of extracellular vesicles. He identified how STEAP-1 positive extracellular vesicles can be diagnostic of prostate cancer more accurately than currently available blood tests, and subsequently developed a novel method to isolate this subpopulation. | Doctor of Philosophy in Pharmaceutical Sciences (PhD) |